Posts Tagged ‘age related macular degeneration’
Expanding excellence in vision care: Welcoming Tanya Alvares to John Rose Eye Care, Kingston Upon Thames, London
At John Rose Eye Care, we continue to redefine clinical excellence in independent optometry by expanding our world-class team and clinical services. We are proud to welcome two esteemed professionals to our Kingston Upon Thames London clinic: Tanya Alvares, BSc (Hons) MCOptom and Dr. Zimar Sivardeen, MBA, PhD, FBCLA, FCOptom, FEAOO. These highly regarded Optometrists …
Read MoreNon-Invasive Dry AMD Therapy available in Kingston upon Thames, London
A breakthrough in photobiomodulation therapy for eye health — at John Rose Eye Care If you or a loved one has been diagnosed with dry Age-related Macular Degeneration (AMD) — or you are at risk and looking for proactive, private eye care in Richmond, Barnes, Surbiton, London or across Surrey — we invite you…
Read MoreValeda LDS – the first and ONLY FDA-authorised treatment for dry AMD to improve vision!
A New Era in Macular Degeneration Care – Safe, Effective and Non-Invasive 🔹 Key Highlights ✅ Rigorous Clinical Trials: LightSite II and LightSite III confirmed effectiveness. ✅ FDA-Approved (November 2024): The first and only treatment using photobiomodulation (PBM) for AMD to receive FDA approval. FDA Approval Announcement ✅Proven Track Record: Over 750,000 treatments performed worldwide…
Read MoreJoin John Rose at 100% Optical: Discover the Valeda Treatment for Dry AMD
If you’re attending 100% Optical, don’t miss the chance to learn from John Rose, the first optometrist in the world to offer the revolutionary Valeda Light Delivery System—the only FDA-approved photobiomodulation treatment for dry age-related macular degeneration (AMD). Age-Related Macular Degeneration is a Leading Cause of Blindness in Adults Over 65. What is the Valeda Light Delivery System? Valeda is a…
Read MoreThe Valeda LDS treatment for dry AMD is now FDA approved
LumiThera has received U.S. FDA authorisation to market its Valeda® Light Delivery System, the first FDA-approved treatment for vision loss due to dry age-related macular degeneration (AMD). The non-invasive photobiomodulation (PBM) device demonstrated improved visual acuity and safety over 24 months in the pivotal LIGHTSITE III trial, with results showing that Valeda slowed disease progression…
Read MoreJohn Rose Features on the “Talking about ‘degeneration” Apple Podcast
Shining a Light on the Future of Photobiomodulation for AMD Listen to John Rose’s interview featured after Dr Clark Tedford, founder of Lumithera Inc in the “Talking about ‘degeneration” Podcast by Angela Young – Cambridge Podcasts. John discusses the Valeda LDS treatment overview for dry AMD patients. John is the world’s first optometrist to offer…
Read MorePhotobiomodulation at John Rose Eye Care
PHOTOBIOMODULATION In 2017 we took the bold step by installing the NoviThor Whole Body Light Pod, a popular device that has revolutionized how we approach whole-body wellness. The NoviThor delivers red and near-infrared light therapy, not just for eye health but for enhancing overall physical well-being. From alleviating chronic pain to boosting energy levels, this…
Read More